Assessment of Lipoprotein (a) and Lipid Profile Pattern in patients of Pre-Eclampsia
Journal: International Journal of Clinical Biochemistry and Research (Vol.4, No. 4)Publication Date: 2017-12-31
Authors : Sunita M. Aghade Jayshree S. Bavikar Shilpa B. Asegaonkar.;
Page : 383-386
Keywords : Pre-eclampsia; Dyslipidemia; Lipid profile; Lipoprotein (a);
Abstract
Introduction: Preeclampsia is a hypertensive disorder of pregnancy characterized by endothelial dysfunction. The present study was planned to assess and compare the levels of serum Lipoprotein (a) and lipid profile in preeclampsia and normal pregnant women and to determine the association of Lp (a) with severity of the disease. Materials and Method: The study comprised of 60 preeclamptic women and 30 normal pregnant women in third trimester of pregnancy. The serum levels of lipoprotein (a) [Lp (a)], triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL) and very low density lipoprotein (VLDL) were determined. Results: A significant alteration in Lp (a) and lipid profile parameters was observed in preeclamptic patients. Serum Lp (a), TG and VLDL were significantly increased while HDL was significantly decreased in preeclamptic group compared to normal pregnant women. Positive correlation was found between serum Lp (a) and blood pressure in preeclampsia patients. Conclusion: The present study demonstrates a dyslipidemic profile in preeclamptic patients. These findings are significant in understanding the pathologic processes of preeclampsia and may help in developing strategies for prevention and early diagnosis of the disorder.
Other Latest Articles
- Lipid profile in Type 2 diabetes mellitus and in diabetic nephropathy
- The synergistic role of CKMB mass and high sensitivity Troponin T in the diagnosis of Acute Coronary Syndrome
- Biochemical markers for early detection of cardiovascular disease in smokers
- Evaluation of Lipid profile levels in acne vulgaris on low dose isotretinoin: A prospective study
- Status of pro-inflammatory Marker IL-6 and Microalbuminuria in type- 2 Diabetic Nephropathy subjects
Last modified: 2018-04-19 19:44:54